These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1280 related articles for article (PubMed ID: 30152206)

  • 21. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
    Dowzicky MJ; Chmelařová E
    J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiological analysis of pathogens causing bloodstream infections in department of hematology in Guangdong Province].
    Zhuo CY; Guo YY; Liu NJ; Liu BM; Xiao SN; Zhang Y; Guo XC; Li DN; Tan SY; He NH; Mai Y; Guan J; Zhuo C
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):996-1001. PubMed ID: 33445846
    [No Abstract]   [Full Text] [Related]  

  • 26. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
    Yang S; Xu H; Sun J; Sun S
    Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
    Zhanel GG; DeCorby M; Adam H; Mulvey MR; McCracken M; Lagacé-Wiens P; Nichol KA; Wierzbowski A; Baudry PJ; Tailor F; Karlowsky JA; Walkty A; Schweizer F; Johnson J; ; Hoban DJ
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4684-93. PubMed ID: 20805395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
    Seifert H; Blondeau J; Dowzicky MJ
    Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro activity of daptomycin and other antimicrobial agents against 499 strains of gram-positive cocci causing bloodstream infection].
    Yang QW; Wang H; Sun HL; Xu YC; Xie XL; Chen MJ
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):220-4. PubMed ID: 19576091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis on distribution and drug resistance of pathogen caused community-onset bloodstream infection].
    Mao S; Ge Z; Zhao H; Cao J; Xia Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):67-72. PubMed ID: 30707872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
    Chen YH; Lu PL; Huang CH; Liao CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1452-7. PubMed ID: 22203598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity against a global collection of skin and skin structure pathogens: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2010-2014.
    Tärnberg M; Nilsson LE; Dowzicky MJ
    Int J Infect Dis; 2016 Aug; 49():141-8. PubMed ID: 27343986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial distribution and drug resistance in blood samples of children in Jiangxi Region, 2017-2021.
    Zhou Y; Zhou S; Peng J; Min L; Chen Q; Ke J
    Front Cell Infect Microbiol; 2023; 13():1163312. PubMed ID: 37424793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia.
    Ngoi ST; Chong CW; Ponnampalavanar SSS; Tang SN; Idris N; Abdul Jabar K; Gregory MJ; Husain T; Teh CSJ
    Antimicrob Resist Infect Control; 2021 Apr; 10(1):70. PubMed ID: 33892804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of nosocomial pneumonia in infants after cardiac surgery.
    Tan L; Sun X; Zhu X; Zhang Z; Li J; Shu Q
    Chest; 2004 Feb; 125(2):410-7. PubMed ID: 14769717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
    Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.